These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
696 related articles for article (PubMed ID: 15612418)
21. Inherited epidermolysis bullosa: epidemiology and patient care in Slovenia with a review of the updated classification. Štublar A; Dragoš V; Dolenc-Voljč M Acta Dermatovenerol Alp Pannonica Adriat; 2021 Jun; 30(2):63-66. PubMed ID: 34169701 [TBL] [Abstract][Full Text] [Related]
22. Gross motor development in children with epidermolysis bullosa. Gorrie A; Saad R; Garside L; Bailie C; Wargon O Child Care Health Dev; 2024 Jan; 50(1):e13194. PubMed ID: 38108617 [TBL] [Abstract][Full Text] [Related]
25. [The genetics of inherited bullous diseases of the skin. Future aspects in perinatal and prenatal diagnosis]. Uitto J Duodecim; 1996; 112(5):368-75. PubMed ID: 10592597 [No Abstract] [Full Text] [Related]
26. Clinical and molecular features in a cohort of Middle Eastern patients with epidermolysis bullosa. Bergson S; Daniely D; Bomze D; Mohamad J; Malovitski K; Meijers O; Briskin V; Bihari O; Malchin N; Israeli S; Mashiah J; Falik-Zaccai T; Avitan-Hersh E; Eskin-Schwartz M; Allon-Shalev S; Sarig O; Sprecher E; Samuelov L Pediatr Dermatol; 2023; 40(6):1021-1027. PubMed ID: 37827535 [TBL] [Abstract][Full Text] [Related]
27. Epidemiology of inherited epidermolysis bullosa in Romania and genotype-phenotype correlations in patients with dystrophic epidermolysis bullosa. Dănescu S; Has C; Senila S; Ungureanu L; Cosgarea R J Eur Acad Dermatol Venereol; 2015 May; 29(5):899-903. PubMed ID: 25201089 [TBL] [Abstract][Full Text] [Related]
28. A case of junctional epidermolysis bullosa intermediate with collagen XVII deficiency treated with dupilumab. Zhang L; Wang S; Chen Q; Xiang L J Dermatolog Treat; 2023 Dec; 34(1):2253943. PubMed ID: 37968922 [TBL] [Abstract][Full Text] [Related]
29. Epidermolysis bullosa in Finland. Clinical features, morphology and relation to collagen metabolism. Kero M Acta Derm Venereol Suppl (Stockh); 1984; 110():1-51. PubMed ID: 6331034 [TBL] [Abstract][Full Text] [Related]
30. Epidemiology of epidermolysis bullosa in the antipodes: the Australasian Epidermolysis Bullosa Registry with a focus on Herlitz junctional epidermolysis bullosa. Kho YC; Rhodes LM; Robertson SJ; Su J; Varigos G; Robertson I; Hogan P; Orchard D; Murrell DF Arch Dermatol; 2010 Jun; 146(6):635-40. PubMed ID: 20566927 [TBL] [Abstract][Full Text] [Related]
31. Inherited blistering diseases of the skin. Fine JD; Johnson LB; Wright JT Pediatrician; 1991; 18(3):175-87. PubMed ID: 1946084 [TBL] [Abstract][Full Text] [Related]
32. [Epidermolysis bullosa gravis Herlitz. A challenge for a pediatric department]. Moster D Tidsskr Nor Laegeforen; 1991 Nov; 111(29):3499-501. PubMed ID: 1796434 [TBL] [Abstract][Full Text] [Related]
33. The eye in epidermolysis bullosa. Tong L; Hodgkins PR; Denyer J; Brosnahan D; Harper J; Russell-Eggitt I; Taylor DS; Atherton D Br J Ophthalmol; 1999 Mar; 83(3):323-6. PubMed ID: 10365041 [TBL] [Abstract][Full Text] [Related]
34. Epidermolysis bullosa. Unrelated to surgery--absolutely related to outcome! What you should know about patients with this complex medical condition. Vail D Todays Surg Nurse; 1997; 19(4):37-40. PubMed ID: 9313587 [No Abstract] [Full Text] [Related]
35. A retrospective analysis of diagnostic testing in a large North American cohort of patients with epidermolysis bullosa. Phillips GS; Huang A; Augsburger BD; Kaplan L; Peoples K; Bruckner AL; Khuu P; Tang JY; Lara-Corrales I; Pope E; Wiss K; Levin LE; Morel KD; Hook KP; Paller AS; Eichenfield LF; McCuaig CC; Powell J; Castelo-Soccio L; Levy ML; Price HN; Schachner LA; Browning JC; Jahnke M; Shwayder T; Bayliss S; Lucky AW; Glick SA J Am Acad Dermatol; 2022 May; 86(5):1063-1071. PubMed ID: 34634382 [TBL] [Abstract][Full Text] [Related]
36. IgA nephropathy in adults with epidermolysis bullosa. Hunjan MK; Bardhan A; Harper N; Balacco DL; Langman G; Suresh V; Heagerty A Clin Exp Dermatol; 2023 Jul; 48(8):920-925. PubMed ID: 37192348 [TBL] [Abstract][Full Text] [Related]
37. Patients suffering from dystrophic epidermolysis bullosa are prone to developing autoantibodies against skin proteins: A longitudinal confirmational study. Bremer J; Pas HH; Diercks GFH; Meijer HJ; van der Molen SM; Nijenhuis AM; van Nijen-Vos LL; Morandé P; Yubero MJ; Palisson F; Fuentes I; Pasmooij AMG Exp Dermatol; 2024 Feb; 33(2):e15035. PubMed ID: 38389191 [TBL] [Abstract][Full Text] [Related]
38. Inherited epidermolysis bullosa: update on the clinical and genetic aspects. Mariath LM; Santin JT; Schuler-Faccini L; Kiszewski AE An Bras Dermatol; 2020; 95(5):551-569. PubMed ID: 32732072 [TBL] [Abstract][Full Text] [Related]
39. Recessive dystrophic epidermolysis bullosa skin displays a chronic growth-activated immunophenotype. Implications for carcinogenesis. Smoller BA; McNutt NS; Carter DM; Gottlieb AB; Hsu A; Krueger J Arch Dermatol; 1990 Jan; 126(1):78-83. PubMed ID: 1688702 [TBL] [Abstract][Full Text] [Related]
40. Development defects of enamel in humans with hereditary epidermolysis bullosa. Wright JT; Johnson LB; Fine JD Arch Oral Biol; 1993 Nov; 38(11):945-55. PubMed ID: 8297258 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]